AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 3 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 8.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $258 | -69.1% | 572 | -80.2% | 0.00% | – |
Q1 2023 | $836 | -41.6% | 2,882 | -9.4% | 0.00% | – |
Q4 2022 | $1,432 | -28.4% | 3,182 | +2.6% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 3,100 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -71.4% | 3,100 | +3.3% | 0.00% | – |
Q1 2022 | $7,000 | -72.0% | 3,000 | -43.4% | 0.00% | – |
Q4 2021 | $25,000 | +1150.0% | 5,300 | +1666.7% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 300 | +50.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 200 | +100.0% | 0.00% | – |
Q3 2020 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |